{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T19:24:22Z","timestamp":1785093862518,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jiac.2014.04.001","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T10:31:25Z","timestamp":1398767485000},"page":"429-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of intravenous azithromycin followed by oral azithromycin for the treatment of acute pelvic inflammatory disease and perihepatitis in Japanese women"],"prefix":"10.1016","volume":"20","author":[{"given":"Hiroshige","family":"Mikamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Iwasaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyako","family":"Matsumizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2014.04.001_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1586\/eri.10.156","article-title":"Recommendations and rationale for the treatment of pelvic inflammatory disease","volume":"9","author":"Jaiyeoba","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2014.04.001_bib2","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1258\/095646207782193911","article-title":"European guideline for the management of pelvic inflammatory disease","volume":"18","author":"Ross","year":"2007","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jiac.2014.04.001_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","article-title":"Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results","volume":"19","author":"Westr\u00f6m","year":"1992","journal-title":"Sex Transm Dis"},{"issue":"RR-12","key":"10.1016\/j.jiac.2014.04.001_bib4","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Pelvic inflammatory disease. In: sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jiac.2014.04.001_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02490164","article-title":"Studies on the clinical implications of anaerobes, especially Prevotella bivia, in obstetrics and gynecology","volume":"4","author":"Mikamo","year":"1998","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2014.04.001_bib6","first-page":"45","article-title":"Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease","volume":"31","author":"Bevan","year":"2003","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.jiac.2014.04.001_bib7","article-title":"Guidelines for the clinical evaluation of anti-infective drug products clinical evaluation","volume":"743","author":"Ministry of Health, Labour and Welfare, Japan","year":"1998","journal-title":"Iyakushin"},{"key":"10.1016\/j.jiac.2014.04.001_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jlb.67.4.495","article-title":"Regulation of phagocytic leukocyte activities by C-reactive protein","volume":"67","author":"Mortensen","year":"2000","journal-title":"J\u00a0Leukoc Biol"},{"issue":"Pt 2","key":"10.1016\/j.jiac.2014.04.001_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/bj2770477","article-title":"Heterogeneous modulation of acute-phase-reactant mRNA levels by interleukin-1 beta and interleukin-6 in the human hepatoma cell line PLC\/PRF\/5","volume":"277","author":"Steel","year":"1991","journal-title":"Biochem J"},{"key":"10.1016\/j.jiac.2014.04.001_bib10","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1002\/j.1460-2075.1989.tb08554.x","article-title":"Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6","volume":"8","author":"Ganter","year":"1989","journal-title":"EMBO J"},{"key":"10.1016\/j.jiac.2014.04.001_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/OLQ.0b013e3181f22f3e","article-title":"Estimation of the rate of pelvic inflammatory disease diagnoses: trends in England, 2000\u20132008","volume":"38","author":"French","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"Suppl.\u00a09A","key":"10.1016\/j.jiac.2014.04.001_bib12","first-page":"5S","article-title":"Clinical implications of the immunomodulatory effects of macrolides","volume":"117","author":"Tamaoki","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jiac.2014.04.001_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00228-011-1161-x","article-title":"Macrolides: from in\u00a0vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases","volume":"68","author":"Zarogoulidis","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2014.04.001_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1086\/431365","article-title":"Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment","volume":"192","author":"Patton","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2014.04.001_bib15","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1128\/AAC.49.5.1787-1793.2005","article-title":"Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis","volume":"49","author":"Reveneau","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.04.001_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/dna.2011.1333","article-title":"Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women","volume":"31","author":"Srivastava","year":"2012","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.jiac.2014.04.001_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/sti.2010.044164","article-title":"European surveillance of antimicrobial resistance in Neisseria gonorrhoeae","volume":"86","author":"Cole","year":"2010","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jiac.2014.04.001_bib18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/OLQ.0b013e31821d0f98","article-title":"Antibiotic-resistant phenotypes and genotypes of Neisseria gonorrhoeae isolates in Japan: identification of strain clusters with multidrug-resistant phenotypes","volume":"38","author":"Tanaka","year":"2011","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jiac.2014.04.001_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jac\/dkp188","article-title":"Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales","volume":"64","author":"Chisholm","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2014.04.001_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/QCO.0b013e328320a836","article-title":"Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins","volume":"22","author":"Tapsall","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jiac.2014.04.001_bib21","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2014.04.001_bib22","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0954-6111(98)90351-1","article-title":"Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis","volume":"92","author":"Omidvari","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.jiac.2014.04.001_bib23","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/archinte.159.21.2576","article-title":"Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia","volume":"159","author":"Stahl","year":"1999","journal-title":"Arch Intern Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14001500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14001500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T20:16:30Z","timestamp":1565381790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X14001500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1341321X14001500"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2014.04.001","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of intravenous azithromycin followed by oral azithromycin for the treatment of acute pelvic inflammatory disease and perihepatitis in Japanese women","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2014.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}